Table of Contents

company-logo

ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. It also offers ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.

ReShape Lifesciences Dividend Announcement

• ReShape Lifesciences does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on ReShape Lifesciences dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

ReShape Lifesciences Dividend History

ReShape Lifesciences Dividend Yield

ReShape Lifesciences current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing ReShape Lifesciences stock? Use our calculator to estimate your expected dividend yield:

ReShape Lifesciences Financial Ratios

P/E ratio-16.92
PEG ratio-0.41
P/B ratio50.28
ROE-208.37%
Payout ratio0.00%
Current ratio1.90
Quick ratio0.89
Cash Ratio0.36

ReShape Lifesciences Dividend FAQ

Does ReShape Lifesciences stock pay dividends?
ReShape Lifesciences does not currently pay dividends to its shareholders.
Has ReShape Lifesciences ever paid a dividend?
No, ReShape Lifesciences has no a history of paying dividends to its shareholders. ReShape Lifesciences is not known for its dividend payments.
Why doesn't ReShape Lifesciences pay dividends?
There are several potential reasons why ReShape Lifesciences would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will ReShape Lifesciences ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While ReShape Lifesciences has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is ReShape Lifesciences a dividend aristocrat?
ReShape Lifesciences is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is ReShape Lifesciences a dividend king?
ReShape Lifesciences is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is ReShape Lifesciences a dividend stock?
No, ReShape Lifesciences is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy ReShape Lifesciences stocks?
To buy ReShape Lifesciences you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy ReShape Lifesciences stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.